PDF) Lymph Node Dissection Technique Is More Important Than Lymph Node Count in Identifying Nodal Metastases in Radical Cystectomy Patients: A Comparative Mapping Study | Eila Skinner - Academia.edu
1906 PREOPERATIVE PULMONARY EMBOLISM DOES NOT PREDICT POOR POSTSURGICAL OUTCOMES IN RCC PATIENTS WITH VENOUS THROMBUS
Fall 2022 Nesbit Society Annual Meeting | Urology | Michigan Medicine | University of Michigan
Renowned urologist Dr. Eila Skinner reflects on her journey in the field
Dr. Eila Skinner - Los Angeles, CA - Urologist Reviews & Ratings - RateMDs
Eila C. Skinner | Stanford Health Care
Clinical Faculty by Specialty | Department of Urology | Stanford Medicine
The Surgeon Who United a Generation of Urology Patients • Trojan Family Magazine
Dr. Eila Skinner, MD - Urology Specialist in Stanford, CA | Healthgrades
1588673941 NPI Number | EILA SKINNER M.D. | STANFORD, CA | NPI Registry | Medical Coding Library | www.HIPAASpace.com © 2023
Dr. Eila Skinner, MD | San Jose, CA | Urology | Vitals
Dr. Skinner: The first woman to receive SUO's Huggins Medal
The Surgeon Who United a Generation of Urology Patients • Trojan Family Magazine
Dr. Sumeet Bhanvadia with... - USC Institute of Urology | Facebook
uehling lectures
2003-2004 Committees
Risk Adapted Treatment of Non-muscle Invasive Bladder Cancer Eila C. Skinner, MD
Eila C. Skinner | Stanford Health Care
PDF) Validation of the AJCC TNM Substaging of pT2 Bladder Cancer: Deep Muscle Invasion Is Associated with Significantly Worse Outcome | Eila Skinner - Academia.edu
Eila Skinner (@ecskinner53) / Twitter
Eila C. Skinner, Stanford University • Expertise Finder Network
CD47 expression and distribution in bladder cancer. (A) Mean CD47 mRNA... | Download Scientific Diagram
SUO 2020: Huggins Lecture: The (Short) History of Women in Urologic Oncology
Dr. Eila Skinner, MD | Stanford, CA | Urologist | US News Doctors
Eila SKINNER | Professor and Chair | Stanford University, CA | SU | Department of Urology | Research profile
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial.,The Lancet - X-MOL
